Description
The TriTom imaging platform uses photoacoustic and fluorescence tomographies to enable high-resolution (up to 160 µm) non-invasive in vivo whole-body imaging of small animals. Multiple excitation wavelengths per scan allow simultaneous photoacoustic and fluorescence acquisition for spectroscopic molecular analysis in large volumes. It enables spatially resolved assessment of physiologic parameters such as volumetric blood content and oxygenation without requiring contrast agents, and supports fluorophores excited between 460 nm and 1320 nm. TriTom excels in preclinical applications such as cancer research, toxicology, developmental biology, and drug development.